Advertisement
Review| Volume 74, ISSUE 1, P21-25, January 2013

Emerging drug therapies for frailty

      Abstract

      The metaphor of a frail older person as a car running out of petrol seems to have resonance in the lay media. Though it may be an over simplistic representation of a complex and dynamic process, it does facilitate discussion with patients and their relatives about the appropriateness of interventions, such as whether or not there is enough fuel (physiological reserves) to get up a really steep hill (undergo a coronary bypass graft). It can also be used as a way to emphasise what can be done to help. For example, in some longitudinal studies, 5% of older patients are less frail after 5 years follow up, suggesting there are things that can still be done to “fill up the tank”. This review will consider whether drug therapies can fulfil this role.
      Frail older people are often prescribed long lists of medications but it is debatable whether current treatments actually address the causes or consequences of frailty itself. Here, we explore the associations between frailty and co-morbidity and evaluate whether the management of chronic disease may impact frailty development or progression. We consider how the management of hypertension may have an important role in the prevention of frailty, mediated by reduction of cerebrovascular disease, but why aggressive management of hypertension may have negative consequences for those who are already frail. We also summarise the evidence linking immunosenescence, inflammation and endocrine changes to frailty and investigate whether targeted drug therapy has the potential to influence frailty pathophysiology.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rockwood K.
        • Song X.
        • Mitnitski A.
        Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey.
        CMAJ: Canadian Medical Association Journal. 2011; 183 ([Epub 2011/05/05]): E487-E494
        • Romero-Ortuno R.
        • Kenny R.A.
        The frailty index in Europeans: association with age and mortality.
        Age and Ageing. 2012; 41 ([Epub 2012/04/24]): 684-689
        • Collard R.M.
        • Boter H.
        • Schoevers R.A.
        • Oude Voshaar R.C.
        Prevalence of frailty in community-dwelling older persons: a systematic review.
        Journal of the American Geriatrics Society. 2012; 60 ([Epub 2012/08/14]): 1487-1492
        • Fried L.P.
        • Ferrucci L.
        • Darer J.
        • Williamson J.D.
        • Anderson G.
        Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care.
        The Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2004; 59 ([Epub 2004/03/20]): 255-263
        • Rockwood K.
        • Mitnitski A.
        Frailty defined by deficit accumulation and geriatric medicine defined by frailty.
        Clinics in Geriatric Medicine. 2011; 27 ([Epub 2010/11/26]): 17-26
        • Mitnitski A.
        • Song X.
        • Rockwood K.
        Trajectories of changes over twelve years in the health status of Canadians from late middle age.
        Experimental Gerontology. 2012; ([Epub 2012/07/14])
        • Gnjidic D.
        • Hilmer S.N.
        • Blyth F.M.
        • et al.
        High-risk prescribing and incidence of frailty among older community-dwelling men.
        Clinical Pharmacology and Therapeutics. 2012; 91 ([Epub 2012/02/03]): 521-528
        • Hubbard R.E.
        • O’Mahony M.S.
        • Woodhouse K.W.
        Medication prescribing in frail older people.
        European Journal of Clinical Pharmacology. 2012; September ([Epub ahead of print])
        • Nardi R.
        • Scanelli G.
        • Corrao S.
        • Iori I.
        • Mathieu G.
        • Cataldi Amatrian R.
        Co-morbidity does not reflect complexity in internal medicine patients.
        European Journal of Internal Medicine. 2007; 18 ([Epub 2007/08/19]): 359-368
        • Theou O.
        • Rockwood M.R.
        • Mitnitski A.
        • Rockwood K.
        Disability and co-morbidity in relation to frailty: how much do they overlap?.
        Archives of Gerontology and Geriatrics. 2012; 55 ([Epub 2012/03/31]): e1-e8
        • Chang S.S.
        • Weiss C.O.
        • Xue Q.L.
        • Fried L.P.
        Association between inflammatory-related disease burden and frailty: results from the Women's Health and Aging Studies (WHAS) I and II.
        Archives of Gerontology and Geriatrics. 2012; 54 ([Epub 2011/07/19]): 9-15
        • Weiss C.O.
        Frailty and chronic diseases in older adults.
        Clinics in Geriatric Medicine. 2011; 27 ([Epub 2010/11/26]): 39-52
        • Hubbard R.E.
        • Woodhouse K.W.
        Frailty, inflammation and the elderly.
        Biogerontology. 2010; 11 ([Epub 2010/06/24]): 635-641
        • Shlipak M.G.
        • Stehman-Breen C.
        • Fried L.F.
        • et al.
        The presence of frailty in elderly persons with chronic renal insufficiency.
        American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation. 2004; 43 ([Epub 2004/04/28]): 861-867
        • Wilhelm-Leen E.R.
        • Hall Y.N.M.K.T.
        • Chertow G.M.
        Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey.
        The American Journal of Medicine. 2009; 122 ([Epub 2009/06/30]): 664-712
        • Bao Y.
        • Dalrymple L.
        • Chertow G.M.
        • Kaysen G.A.
        • Johansen K.L.
        Frailty, dialysis initiation, and mortality in end-stage renal disease.
        Archives of Internal Medicine. 2012; 172 ([Epub 2012/06/27]): 1071-1077
        • Johansen K.L.
        • Chertow G.M.
        • Jin C.
        • Kutner NG
        Significance of frailty among dialysis patients.
        Journal of the American Society of Nephrology: JASN. 2007; 18 ([Epub 2007/10/19]): 2960-2967
        • Chadban S.J.
        • Briganti E.M.
        • Kerr P.G.
        • et al.
        Prevalence of kidney damage in Australian adults: the AusDiab kidney study.
        Journal of the American Society of Nephrology: JASN. 2003; 14 ([Epub 2003/06/24]): S131-S138
        • Zamboli P.
        • Nicola L.
        • Minutolo R.
        • Bertino V.
        • Catapano F.
        • Conte G.
        Management of hypertension in chronic kidney disease.
        Current Science. 2006; 8: 497-501
        • Abellan van Kan G.
        • Rolland Y.
        • Andrieu S.
        • et al.
        Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force.
        The Journal of Nutrition, Health & Aging. 2009; 13 ([Epub 2009/11/20]): 881-889
        • Rothman M.D.
        • Leo-Summers L.
        • Gill T.M.
        Prognostic significance of potential frailty criteria.
        Journal of the American Geriatrics Society. 2008; 56 ([Epub 2008/12/20]): 2211-3116
        • Rosano C.
        • Bennett D.A.
        • Newman A.B.
        • et al.
        Patterns of focal gray matter atrophy are associated with bradykinesia and gait disturbances in older adults.
        The Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2012; 67 ([Epub 2012/03/01]): 957-962
        • Rosano C.
        • Studenski S.A.
        • Aizenstein H.J.
        • Boudreau R.M.
        • Longstreth Jr., W.T.
        • Newman A.B.
        Slower gait, slower information processing and smaller prefrontal area in older adults.
        Age and Ageing. 2012; 41 ([Epub 2011/10/04]): 58-64
        • Rosano C.
        • Longstreth Jr., W.T.
        • Boudreau R.
        • et al.
        High blood pressure accelerates gait slowing in well-functioning older adults over 18-years of follow-up.
        Journal of the American Geriatrics Society. 2011; 59 ([Epub 2011/03/12]): 390-397
        • Hajjar I.
        • Quach L.
        • Yang F.
        • et al.
        Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the Cardiovascular Health Study.
        Circulation. 2011; 123 ([Epub 2011/02/16]): 858-865
        • Buchman A.S.
        • Schneider J.A.
        • Leurgans S.
        • Bennett D.A.
        Physical frailty in older persons is associated with Alzheimer disease pathology.
        Neurology. 2008; 71 ([Epub 2008/08/13]): 499-504
        • Song X.
        • Mitnitski A.
        • Rockwood K.
        Nontraditional risk factors combine to predict Alzheimer disease and dementia.
        Neurology. 2011; 77 ([Epub 2011/07/15]): 227-234
        • Lee J.S.
        • Auyeung T.W.
        • Leung J.
        • Kwok T.
        • Leung P.C.
        • Woo J.
        Physical frailty in older adults is associated with metabolic and atherosclerotic risk factors and cognitive impairment independent of muscle mass.
        The Journal of Nutrition, Health & Aging. 2011; 15 ([Epub 2011/12/14]): 857-862
        • Danon-Hersch N.
        • Rodondi N.
        • Spagnoli J.
        • Santos-Eggimann B.
        Prefrailty and chronic morbidity in the youngest old: an insight from the lausanne cohort lc65+.
        Journal of the American Geriatrics Society. 2012; 60 ([Epub 2012/08/22]): 1687-1694
        • Payne G.W.
        Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control.
        Microcirculation. 2006; 13: 343-352
        • Koopman R.
        • Ryall J.G.
        • Church J.E.
        • Lynch G.S.
        The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.
        Current Opinion in Clinical Nutrition and Metabolic Care. 2009; 12 ([Epub 2009/09/11]): 601-606
        • Sumukadas D.
        • Witham M.D.
        • Struthers A.D.
        • McMurdo M.E.
        Ace inhibitors as a therapy for sarcopenia – evidence and possible mechanisms.
        The Journal of Nutrition, Health & Aging. 2008; 12 ([Epub 2008/07/11]): 480-485
        • Odden M.C.
        • Peralta C.A.
        • Haan M.N.
        • Covinsky K.E.
        Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty.
        Archives of Internal Medicine. 2012; 172 ([Epub 2012/07/18]): 1162-1168
        • Gueyffier F.
        • Bulpitt C.
        • Boissel J.P.
        • et al.
        Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group.
        Lancet. 1999; 353 ([Epub 1999/08/25]): 793-796
        • Beckett N.S.
        • Peters R.
        • Fletcher A.E.
        • et al.
        Treatment of hypertension in patients 80 years of age or older.
        The New England Journal of Medicine. 2008; 358 ([Epub 2008/04/02]): 1887-1898
        • Ridda I.
        • Macintyre C.R.
        • Lindley R.
        • et al.
        Immunological responses to pneumococcal vaccine in frail older people.
        Vaccine. 2009; 27 ([Epub 2008/12/23]): 1628-1636
        • Bandeen-Roche K.
        • Walston J.D.
        • Huang Y.
        • Semba R.D.
        • Ferrucci L.
        Measuring systemic inflammatory regulation in older adults: evidence and utility.
        Rejuvenation Research. 2009; 12 ([Epub 2010/01/01]): 403-410
        • Fried L.P.
        • Xue Q.L.
        • Cappola A.R.
        • et al.
        Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment.
        The Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2009; 64 ([Epub 2009/07/02]): 1049-1057
        • LaCroix A.Z.
        • Gray S.L.
        • Aragaki A.
        • et al.
        Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study.
        The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2008; 63 ([Epub 2008/04/23]): 369-375
        • Perrini S.
        • Laviola L.
        • Carreira M.C.
        • Cignarelli A.
        • Natalicchio A.
        • Giorgino F.
        The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis.
        The Journal of Endocrinology. 2010; 205 ([Epub 2010/03/04]): 201-210
        • Liu H.
        • Bravata D.M.
        • Olkin I.
        • et al.
        Systematic review: the safety and efficacy of growth hormone in the healthy elderly.
        Annals of Internal Medicine. 2007; 146 ([Epub 2007/01/18]): 104-115
        • Mohr B.A.
        • Bhasin S.
        • Kupelian V.
        • Araujo A.B.
        • O’Donnell A.B.
        • McKinlay J.B.
        Testosterone, sex hormone-binding globulin, and frailty in older men.
        Journal of the American Geriatrics Society. 2007; 55 ([Epub 2007/04/03]): 548-555
        • Hyde Z.
        • Flicker L.
        • Almeida O.P.
        • et al.
        Low free testosterone predicts frailty in older men: the health in men study.
        The Journal of Clinical Endocrinology and Metabolism. 2010; 95 ([Epub 2010/04/23]): 3165-3172
        • Srinivas-Shankar U.
        • Roberts S.A.
        • Connolly M.J.
        • et al.
        Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study.
        The Journal of Clinical Endocrinology and Metabolism. 2010; 95 ([Epub 2010/01/12]): 639-650
        • O’Connell M.D.
        • Roberts S.A.
        • Srinivas-Shankar U.
        • et al.
        Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men?.
        The Journal of Clinical Endocrinology and Metabolism. 2011; 96 ([Epub 2010/11/19]): 454-458
        • Sullivan D.H.
        • Roberson P.K.
        • Johnson L.E.
        • et al.
        Effects of muscle strength training and testosterone in frail elderly males.
        Medicine and Science in Sports and Exercise. 2005; 37 ([Epub 2005/11/02]): 1664-1672
        • Fernandez-Balsells M.M.
        • Murad M.H.
        • Lane M.
        • et al.
        Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.
        The Journal of Clinical Endocrinology and Metabolism. 2010; 95 ([Epub 2010/06/09]): 2560-2575
        • Reuben D.B.
        • Hirsch S.H.
        • Zhou K.
        • Greendale G.A.
        The effects of megestrol acetate suspension for elderly patients with reduced appetite after hospitalization: a phase II randomized clinical trial.
        Journal of the American Geriatrics Society. 2005; 53 ([Epub 2005/06/07]): 970-975
        • Kenny A.M.
        • Boxer R.S.
        • Kleppinger A.
        • Brindisi J.
        • Feinn R.
        • Burleson J.A.
        Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women.
        Journal of the American Geriatrics Society. 2010; 58 ([Epub 2010/09/25]): 1707-1714
        • Baker W.L.
        • Karan S.
        • Kenny A.M.
        Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: a systematic review.
        Journal of the American Geriatrics Society. 2011; 59 ([Epub 2011/06/09]): 997-1002
        • Davis S.R.
        • Panjari M.
        • Stanczyk F.Z.
        Clinical review: DHEA replacement for postmenopausal women.
        Journal of Clinical Endocrinology and Metabolism. 2011; 96: 1642-1653
        • Nass R.
        • Pezzoli S.S.
        • Oliveri M.C.
        • et al.
        Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.
        Annals of Internal Medicine. 2008; 149 ([Epub 2008/11/05]): 601-611
        • Spitznagel M.B.
        • Benitez A.
        • Updegraff J.
        • et al.
        Serum ghrelin is inversely associated with cognitive function in a sample of non-demented elderly.
        Psychiatry and Clinical Neurosciences. 2010; 64 ([Epub 2010/10/30]): 608-611
        • Hubbard R.E.
        • Fallah N.
        • Searle S.D.
        • Mitnitski A.
        • Rockwood K.
        Impact of exercise in community-dwelling older adults.
        PLoS One. 2009; 4: e6174
        • Hubbard R.E.
        • Lang I.A.
        • Llewellyn D.J.
        • Rockwood K.
        Frailty, body mass index, and abdominal obesity in older people.
        Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2010; 65: 377-381